Clinical Trial Update: A Phase I Study of CREPT-618 in Locally Advanced HCC [Phase 1]

View source ↗

Summary

Phase I study evaluating CREPT-618 in locally advanced Hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CREPT-618

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1 | Status: RECRUITING